EquityZen Growth Technology Fund LLC - Series 59
Raised
$583K
Investors
19
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 59 is a Delaware pooled investment vehicle that raised $583K from 19 investors under Rule 506(b) and Section 3(c)(1). This amended filing, dated December 2016, is part of the EquityZen platform, which operates over 1,800 pre-IPO investment entities. Management includes EquityZen Inc., Shriram Bhashyam, Assure Fund Management II LLC, and Mateo Johnson.
This Series vehicle represents a typical sub-$1M SPV structure in the pre-IPO secondary market, using the standard 506(b)/3(c)(1) exemption pairing common to pooled funds targeting accredited investors. The ~$31K average commitment per investor is consistent with EquityZen's retail-accessible model for accessing private company equity.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Inc.
Executive Officer, Director · New York, NY
Shriram Bhashyam
Executive Officer, Director · New York, NY
Assure Fund Management II LLC
Director · Salt Lake City, UT
Mateo Johnson
Executive Officer · Salt Lake City, UT
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
